CN118184700A - A phosphoric acid-enriched chemical cross-linking agent and its preparation and application - Google Patents
A phosphoric acid-enriched chemical cross-linking agent and its preparation and application Download PDFInfo
- Publication number
- CN118184700A CN118184700A CN202211596866.4A CN202211596866A CN118184700A CN 118184700 A CN118184700 A CN 118184700A CN 202211596866 A CN202211596866 A CN 202211596866A CN 118184700 A CN118184700 A CN 118184700A
- Authority
- CN
- China
- Prior art keywords
- reaction
- compound
- cross
- linking agent
- ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003431 cross linking reagent Substances 0.000 title claims abstract description 39
- 238000010382 chemical cross-linking Methods 0.000 title claims abstract description 11
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 title claims description 8
- 229910000147 aluminium phosphate Inorganic materials 0.000 title claims description 4
- 238000006243 chemical reaction Methods 0.000 claims abstract description 45
- 238000004458 analytical method Methods 0.000 claims abstract description 16
- -1 succinimide ester Chemical class 0.000 claims abstract description 12
- 108010052285 Membrane Proteins Proteins 0.000 claims abstract description 11
- 102000018697 Membrane Proteins Human genes 0.000 claims abstract description 10
- 210000000170 cell membrane Anatomy 0.000 claims abstract description 8
- 238000007112 amidation reaction Methods 0.000 claims abstract description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 51
- 239000000243 solution Substances 0.000 claims description 39
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 29
- 239000012071 phase Substances 0.000 claims description 19
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 16
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 15
- 150000002148 esters Chemical class 0.000 claims description 15
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 229940126214 compound 3 Drugs 0.000 claims description 11
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims description 10
- 229940125904 compound 1 Drugs 0.000 claims description 10
- 229940125782 compound 2 Drugs 0.000 claims description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims description 7
- 239000000126 substance Substances 0.000 claims description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 239000000945 filler Substances 0.000 claims description 5
- 239000007791 liquid phase Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 239000007810 chemical reaction solvent Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 238000005886 esterification reaction Methods 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 150000007530 organic bases Chemical class 0.000 claims description 4
- 230000035484 reaction time Effects 0.000 claims description 4
- 238000002390 rotary evaporation Methods 0.000 claims description 4
- KUQZVISZELWDNZ-UHFFFAOYSA-N 3-aminopropyl dihydrogen phosphate Chemical compound NCCCOP(O)(O)=O KUQZVISZELWDNZ-UHFFFAOYSA-N 0.000 claims description 3
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical group OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000005191 phase separation Methods 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 239000012230 colorless oil Substances 0.000 claims description 2
- 238000004440 column chromatography Methods 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000012074 organic phase Substances 0.000 claims description 2
- 239000000741 silica gel Substances 0.000 claims description 2
- 229910002027 silica gel Inorganic materials 0.000 claims description 2
- 239000007858 starting material Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 3
- LEJONDPNCGKOBF-UHFFFAOYSA-N 4-(2-carboxyethyl)heptanedioic acid Chemical compound OC(=O)CCC(CCC(O)=O)CCC(O)=O LEJONDPNCGKOBF-UHFFFAOYSA-N 0.000 claims 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims 2
- GSZQTIFGANBTNF-UHFFFAOYSA-N (3-aminopropyl)phosphonic acid Chemical compound NCCCP(O)(O)=O GSZQTIFGANBTNF-UHFFFAOYSA-N 0.000 claims 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims 1
- 239000012295 chemical reaction liquid Substances 0.000 claims 1
- 239000011259 mixed solution Substances 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 230000004850 protein–protein interaction Effects 0.000 claims 1
- 239000000376 reactant Substances 0.000 claims 1
- 229910052710 silicon Inorganic materials 0.000 claims 1
- 239000010703 silicon Substances 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 29
- 102000004169 proteins and genes Human genes 0.000 abstract description 26
- 108090000623 proteins and genes Proteins 0.000 abstract description 26
- 238000004132 cross linking Methods 0.000 abstract description 24
- 239000002202 Polyethylene glycol Substances 0.000 abstract description 13
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 abstract description 13
- 229920001223 polyethylene glycol Polymers 0.000 abstract description 13
- 230000003993 interaction Effects 0.000 abstract description 10
- 125000003277 amino group Chemical group 0.000 abstract description 7
- 108091054442 EV proteins Proteins 0.000 abstract description 4
- 108091058545 Secretory proteins Proteins 0.000 abstract description 4
- 102000040739 Secretory proteins Human genes 0.000 abstract description 4
- KZNICNPSHKQLFF-UHFFFAOYSA-N dihydromaleimide Natural products O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 abstract description 4
- 229960002317 succinimide Drugs 0.000 abstract description 4
- 108050001049 Extracellular proteins Proteins 0.000 abstract description 3
- 238000001042 affinity chromatography Methods 0.000 abstract description 3
- 230000003834 intracellular effect Effects 0.000 abstract description 3
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 abstract description 3
- 239000002184 metal Substances 0.000 abstract description 3
- 230000000149 penetrating effect Effects 0.000 abstract description 3
- 239000007790 solid phase Substances 0.000 abstract description 2
- 102100021935 C-C motif chemokine 26 Human genes 0.000 abstract 1
- 101000897493 Homo sapiens C-C motif chemokine 26 Proteins 0.000 abstract 1
- 239000004971 Cross linker Substances 0.000 description 35
- 239000000523 sample Substances 0.000 description 18
- 102000004196 processed proteins & peptides Human genes 0.000 description 15
- 238000004949 mass spectrometry Methods 0.000 description 10
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 8
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 8
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 8
- 239000001099 ammonium carbonate Substances 0.000 description 8
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 7
- ZWIBGKZDAWNIFC-UHFFFAOYSA-N disuccinimidyl suberate Chemical compound O=C1CCC(=O)N1OC(=O)CCCCCCC(=O)ON1C(=O)CCC1=O ZWIBGKZDAWNIFC-UHFFFAOYSA-N 0.000 description 6
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 6
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 5
- 102000003846 Carbonic anhydrases Human genes 0.000 description 5
- 108090000209 Carbonic anhydrases Proteins 0.000 description 5
- 229940098773 bovine serum albumin Drugs 0.000 description 5
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 5
- OBMZMSLWNNWEJA-XNCRXQDQSA-N C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 Chemical compound C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 OBMZMSLWNNWEJA-XNCRXQDQSA-N 0.000 description 4
- 101710176384 Peptide 1 Proteins 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000001597 immobilized metal affinity chromatography Methods 0.000 description 4
- 230000006916 protein interaction Effects 0.000 description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000008568 cell cell communication Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 3
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 3
- 239000010413 mother solution Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical group N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- TVZRAEYQIKYCPH-UHFFFAOYSA-N 3-(trimethylsilyl)propane-1-sulfonic acid Chemical compound C[Si](C)(C)CCCS(O)(=O)=O TVZRAEYQIKYCPH-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000012482 interaction analysis Methods 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 230000004962 physiological condition Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- VHJLVAABSRFDPM-IMJSIDKUSA-N L-1,4-dithiothreitol Chemical compound SC[C@H](O)[C@@H](O)CS VHJLVAABSRFDPM-IMJSIDKUSA-N 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 108010026552 Proteome Proteins 0.000 description 1
- 101100012902 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FIG2 gene Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000023402 cell communication Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009510 drug design Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000001114 immunoprecipitation Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000035992 intercellular communication Effects 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 238000001086 yeast two-hybrid system Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N2030/067—Preparation by reaction, e.g. derivatising the sample
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Peptides Or Proteins (AREA)
Abstract
本发明涉及一种可富集型化学交联剂的制备方法及其应用。本交联剂具有以下功能特点:1)具有磷酸基团,适用于基于固相金属亲和色谱(IMAC)的磷酸化肽富集策略,同时磷酸基团增加了交联剂的亲水性,生物兼容性更好;2)具有两个琥珀酰亚胺酯结构单元,该基团可与蛋白质的赖氨酸残基末端氨基或蛋白质N端氨基发生酰胺化反应,反应条件温和,反应效率高;3)分子骨架结构引入聚乙二醇(PEG)链,可以提高交联剂的亲水性,结合磷酸基团的亲水性,抑制交联剂透过细胞膜引起细胞内蛋白质交联,使其适用于细胞外蛋白质(如细胞表面蛋白质、分泌蛋白质、细胞外囊泡蛋白质)的特异性分析,获得上述蛋白质的结构和相互作用信息。
The present invention relates to a preparation method and application of an enrichable chemical cross-linking agent. The cross-linking agent has the following functional characteristics: 1) it has a phosphate group, which is suitable for the phosphorylated peptide enrichment strategy based on solid phase metal affinity chromatography (IMAC), and the phosphate group increases the hydrophilicity of the cross-linking agent, and has better biocompatibility; 2) it has two succinimide ester structural units, which can react with the terminal amino group of the lysine residue of the protein or the N-terminal amino group of the protein to undergo an amidation reaction, and the reaction conditions are mild and the reaction efficiency is high; 3) the molecular skeleton structure introduces a polyethylene glycol (PEG) chain, which can improve the hydrophilicity of the cross-linking agent, and combined with the hydrophilicity of the phosphate group, inhibits the cross-linking agent from penetrating the cell membrane to cause intracellular protein cross-linking, making it suitable for specific analysis of extracellular proteins (such as cell surface proteins, secretory proteins, and extracellular vesicle proteins), and obtaining the structure and interaction information of the above proteins.
Description
技术领域Technical Field
本发明涉及一种可富集型化学交联剂及其制备方法和应用。本发明交联剂是一种多功能的化学交联剂,具有一个磷酸富集基团、两个琥珀酰亚胺酯基团。为了获得更丰富的交联信息,在分子骨架中引入PEG链以改变分子的交联半径并增加分子的柔性,同时,PEG链可以增加分子的亲水特性。在生理条件下,本交联剂的磷酸基团带有负电荷,结合PEG链的强亲水性,使得本交联剂无法透过细胞膜,因此可以实现细胞表面蛋白质复合体的结构和相互作用分析以及细胞外成分,如分泌蛋白质和细胞外囊泡蛋白质介导的与细胞间通讯相关相互作用分析。The present invention relates to an enrichable chemical cross-linking agent and a preparation method and application thereof. The cross-linking agent of the present invention is a multifunctional chemical cross-linking agent having a phosphate enriched group and two succinimide ester groups. In order to obtain richer cross-linking information, a PEG chain is introduced into the molecular skeleton to change the cross-linking radius of the molecule and increase the flexibility of the molecule. At the same time, the PEG chain can increase the hydrophilicity of the molecule. Under physiological conditions, the phosphate group of the cross-linking agent carries a negative charge, and combined with the strong hydrophilicity of the PEG chain, the cross-linking agent cannot penetrate the cell membrane, so that the structure and interaction analysis of the cell surface protein complex and the extracellular components, such as secretory proteins and extracellular vesicle proteins, can be realized. Interaction analysis related to cell-to-cell communication.
背景技术Background technique
蛋白质是生命活动的执行者,蛋白质结构处在动态变化之中且与其功能密切相关。细胞表面蛋白质在细胞粘附、信号转导、物质交换、免疫应答以及细胞通讯等生命活动中起到非常重要的作用。它们是广泛的药物设计靶标,是细胞间通讯的相互识别位点,是重要的疾病诊断、治疗及预后的标志物分子来源,并常用作特定类型细胞分选和分类的标志物分子。通常情况下,多个蛋白质组成复合物发挥其功能。因此,研究细胞表面蛋白质复合物的结构及相互作用对于了解蛋白质功能、解析细胞间信息交流、解释和预测各种生命现象起着至关重要的作用。Proteins are the executors of life activities. The structure of proteins is in dynamic change and is closely related to their functions. Cell surface proteins play a very important role in life activities such as cell adhesion, signal transduction, material exchange, immune response and cell communication. They are widely used as drug design targets, mutual recognition sites for intercellular communication, important sources of marker molecules for disease diagnosis, treatment and prognosis, and are often used as marker molecules for sorting and classification of specific types of cells. Usually, multiple proteins form a complex to perform their functions. Therefore, studying the structure and interaction of cell surface protein complexes plays a vital role in understanding protein functions, analyzing intercellular information exchange, and explaining and predicting various life phenomena.
近年来,化学交联质谱技术(CXMS)在研究蛋白质结构及其相互作用领域扮演着重要角色。相比酵母双杂交、免疫共沉淀、核磁共振、X射线衍射等传统技术,化学交联质谱技术具有独特的优势,如适用于复杂的样品体系(亚细胞器、细胞、组织等)、能够捕获瞬时和弱的蛋白质相互作用、解析生理条件下原位动态的蛋白质相互作用等。In recent years, chemical cross-linking mass spectrometry (CXMS) has played an important role in the study of protein structure and its interactions. Compared with traditional techniques such as yeast two-hybrid, immunoprecipitation, nuclear magnetic resonance, and X-ray diffraction, chemical cross-linking mass spectrometry has unique advantages, such as being applicable to complex sample systems (subcellular organelles, cells, tissues, etc.), being able to capture transient and weak protein interactions, and analyzing dynamic protein interactions in situ under physiological conditions.
交联剂常见的功能基团包括琥珀酰亚胺酯(与氨基反应)、马来酰亚胺(与巯基反应)等。其中琥珀酰亚胺酯的反应活性好,应用广泛,可以实现表面蛋白质复合物机构和相互作用分析。交联后的蛋白质样品酶解成肽段,进而采用蛋白质组学由底而上的(bottom-up)策略,实现交联肽的鉴定以及蛋白质结构及相互作用的解析。针对复杂的生物样品,尤其细胞或组织样品,由于蛋白质种类多、丰度跨度大,以及交联反应效率有限,导致酶解后的样品成分复杂,其中交联肽含量极低,因此质谱鉴定极其困难。因此,为了提高交联肽的比例及质谱鉴定的灵敏度,同时降低常规肽段的背景干扰,人们开发多了各种各样的富集型交联剂。生物素-链霉亲和素系统是常见的富集方法。由于生物素基团产生较大反应位阻影响交联反应效率以及交联肽疏水性增强,不利于质谱鉴定;人们又开发了含有炔基(叠氮)的交联剂,虽然这种富集方式已成功应用于细胞蛋白质结构及其相互作用的规模化分析,但仍存在操作步骤繁琐,样品回收率低等问题。Common functional groups of cross-linking agents include succinimidyl esters (reacting with amino groups), maleimide (reacting with sulfhydryl groups), etc. Among them, succinimidyl esters have good reactivity and are widely used. They can realize the analysis of surface protein complex structure and interaction. The cross-linked protein samples are enzymatically hydrolyzed into peptides, and then the bottom-up strategy of proteomics is adopted to realize the identification of cross-linked peptides and the analysis of protein structure and interaction. For complex biological samples, especially cell or tissue samples, due to the large number of protein types, large abundance span, and limited cross-linking reaction efficiency, the sample composition after enzymatic hydrolysis is complex, and the content of cross-linked peptides is extremely low, so mass spectrometry identification is extremely difficult. Therefore, in order to increase the proportion of cross-linked peptides and the sensitivity of mass spectrometry identification, while reducing the background interference of conventional peptides, people have developed a variety of enrichment cross-linking agents. The biotin-streptavidin system is a common enrichment method. Since the biotin group produces a large reaction steric hindrance that affects the efficiency of the cross-linking reaction and enhances the hydrophobicity of the cross-linked peptide, it is not conducive to mass spectrometry identification; people have developed cross-linking agents containing alkynyl groups (azide). Although this enrichment method has been successfully applied to the large-scale analysis of cellular protein structure and its interactions, there are still problems such as cumbersome operation steps and low sample recovery rate.
固相金属亲和色谱(IMAC)是利用磷酸基团与固相化的Fe3+、Ga2+及Cu2+等金属离子的亲和来富集磷酸化肽,具有特异性好、结合力强、易于洗脱释放的优点,在磷酸化蛋白质组具有广泛的应用。因此人们在交联剂上结合磷酸基团,实现了更高效的交联肽富集方法。Immobilized metal affinity chromatography (IMAC) enriches phosphorylated peptides by using the affinity of phosphate groups with immobilized metal ions such as Fe 3+ , Ga 2+ and Cu 2+ . It has the advantages of good specificity, strong binding force and easy elution and release, and is widely used in phosphorylated proteomes. Therefore, people combine phosphate groups on cross-linkers to achieve a more efficient cross-linked peptide enrichment method.
发明内容Summary of the invention
基于以上研究背景及现状,本发明设计并合成了一种磷酸富集型化学交联剂。本发明交联剂具有磷酸富集单元,交联反应得到的交联肽段含有磷酸基团,适用于基于固相金属亲和色谱(IMAC)的磷酸化肽富集策略,可大幅降低样品中常规肽段的干扰,进而增强交联肽段在质谱检测中的信号强度,实现交联肽段高灵敏度鉴定,同时磷酸基团增加了交联剂的亲水性,生物兼容性更好;具有两个琥珀酰亚胺酯结构单元。该基团可与蛋白质的赖氨酸残基末端氨基或蛋白质N端氨基发生酰胺化反应,反应条件温和,反应效率高;分子骨架结构引入聚乙二醇(PEG)链,可以提高交联剂的亲水性,结合磷酸基团的亲水性,抑制交联剂透过细胞膜引起细胞内蛋白质交联,使其适用于细胞外蛋白质(如细胞表面蛋白质、分泌蛋白质、细胞外囊泡蛋白质)的特异性分析,获得上述蛋白质的结构和相互作用信息。同时,PEG可提高交联剂的柔性,并可通过PEG链长度的调整,改变交联剂分子的交联半径,有利于捕获更多的蛋白质相互作用信息。本发明交联剂应用于细胞表面蛋白质结构及相互作用分析,同时为实现分泌蛋白、细胞外囊泡介导的细胞间通讯研究提供重要的技术支撑。Based on the above research background and status, the present invention designs and synthesizes a phosphate-enriched chemical cross-linking agent. The cross-linking agent of the present invention has a phosphate-enriched unit, and the cross-linked peptide obtained by the cross-linking reaction contains a phosphate group, which is suitable for the phosphorylated peptide enrichment strategy based on solid metal affinity chromatography (IMAC), which can greatly reduce the interference of conventional peptides in the sample, thereby enhancing the signal intensity of the cross-linked peptide in mass spectrometry detection, and realizing high-sensitivity identification of cross-linked peptides. At the same time, the phosphate group increases the hydrophilicity of the cross-linking agent, and the biocompatibility is better; it has two succinimide ester structural units. This group can undergo an amidation reaction with the terminal amino group of the lysine residue of the protein or the N-terminal amino group of the protein, and the reaction conditions are mild and the reaction efficiency is high; the molecular skeleton structure introduces a polyethylene glycol (PEG) chain, which can improve the hydrophilicity of the cross-linking agent, combine the hydrophilicity of the phosphate group, inhibit the cross-linking agent from penetrating the cell membrane to cause intracellular protein cross-linking, and make it suitable for the specific analysis of extracellular proteins (such as cell surface proteins, secreted proteins, and extracellular vesicle proteins), and obtain the structure and interaction information of the above proteins. At the same time, PEG can improve the flexibility of the crosslinker, and can change the crosslinking radius of the crosslinker molecule by adjusting the length of the PEG chain, which is conducive to capturing more protein interaction information. The crosslinker of the present invention is applied to the analysis of cell surface protein structure and interaction, and provides important technical support for the study of secretory proteins and extracellular vesicle-mediated cell-to-cell communication.
本发明提供的多功能交联剂,结构如下所示:The multifunctional cross-linking agent provided by the present invention has the following structure:
本发明提供了交联剂的制备方法,具体步骤如下:The present invention provides a method for preparing a cross-linking agent, and the specific steps are as follows:
第一步,以4-(2-羧基乙基)庚二酸(化合物0)为起始原料,1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐(以下简称EDCI)为缩合剂,N-羟基琥珀酰亚胺(以下简称NHS)为羟基供体,二氯甲烷(以下简称DCM)为反应溶剂,发生酯化反应制备癸三琥珀酰亚胺酯(化合物1);反应完毕,经液相分离纯化,得到癸三琥珀酰亚胺酯溶液,经旋转蒸发干燥获得癸三琥珀酰亚胺酯(化合物1)。In the first step, 4-(2-carboxyethyl) heptane dicarboxylic acid (compound 0) is used as a starting material, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (hereinafter referred to as EDCI) is used as a condensation agent, N-hydroxysuccinimide (hereinafter referred to as NHS) is used as a hydroxyl donor, and dichloromethane (hereinafter referred to as DCM) is used as a reaction solvent to undergo an esterification reaction to prepare decantrisuccinimide ester (compound 1); after the reaction is completed, the decantrisuccinimide ester solution is obtained by liquid phase separation and purification, and the decantrisuccinimide ester solution is obtained by rotary evaporation and drying to obtain decantrisuccinimide ester (compound 1).
第二步,以步骤一所得癸三琥珀酰亚胺酯(化合物1)为原料,进行酰胺化反应,加入氨基-PEG3-羧酸以及有机碱三乙胺(以下简称TEA),制备三PEG3-三羧酸(化合物2)。In the second step, the trisuccinimidyl ester (compound 1) obtained in step 1 is used as a raw material to carry out an amidation reaction, and amino-PEG3-carboxylic acid and an organic base triethylamine (hereinafter referred to as TEA) are added to prepare triPEG3-tricarboxylic acid (compound 2).
第三步,以化合物2为反应原料,EDCI为缩合剂,NHS为羟基供体,DMSO为反应溶剂,发生酯化反应,制备三PEG3-三琥珀酰亚胺酯(化合物3)。In the third step, an esterification reaction is carried out using compound 2 as a reaction raw material, EDCI as a condensation agent, NHS as a hydroxyl donor, and DMSO as a reaction solvent to prepare triPEG3-trisuccinimide ester (compound 3).
第四步,以化合物3及氨丙基磷酸为原料,摩尔比控制在1:1,TEA为有机碱,DMSO为反应溶液,发生酰胺化反应,制备PDSE(目标交联剂)。In the fourth step, compound 3 and aminopropyl phosphate were used as raw materials, the molar ratio was controlled at 1:1, TEA was used as an organic base, and DMSO was used as a reaction solution, and an amidation reaction occurred to prepare PDSE (target cross-linking agent).
本发明中所述的磷酸富集型化学交联剂的合成路线如下:The synthetic route of the phosphoric acid-enriched chemical cross-linking agent described in the present invention is as follows:
本发明交联剂应用于细胞表面蛋白质结构及相互作用分析,同时为实现分泌蛋白、细胞外囊泡介导的细胞间通讯研究提供重要的技术支撑。The cross-linking agent of the present invention is applied to the analysis of the structure and interaction of cell surface proteins, and provides important technical support for the study of secretory proteins and extracellular vesicle-mediated cell-to-cell communication.
与现有化学交联剂相比,本发明交联剂具有如下优点:Compared with existing chemical crosslinking agents, the crosslinking agent of the present invention has the following advantages:
1.具有磷酸基团。交联反应得到的交联肽段含有磷酸基团,适用于基于固相金属亲和色谱(IMAC)的磷酸化肽富集策略,可大幅降低样品中常规肽段的干扰,进而增强交联肽段在质谱检测中的信号强度,实现交联肽段高灵敏度鉴定,同时磷酸基团增加了交联剂的亲水性,生物兼容性更好;1. Contains phosphate groups. The cross-linked peptides obtained by the cross-linking reaction contain phosphate groups, which are suitable for phosphorylated peptide enrichment strategies based on solid phase metal affinity chromatography (IMAC). They can significantly reduce the interference of conventional peptides in the sample, thereby enhancing the signal intensity of cross-linked peptides in mass spectrometry detection and achieving high-sensitivity identification of cross-linked peptides. At the same time, the phosphate groups increase the hydrophilicity of the cross-linker and have better biocompatibility.
2.具有两个琥珀酰亚胺酯结构单元。该基团可与蛋白质的赖氨酸残基末端氨基或蛋白质N端氨基发生酰胺化反应,反应条件温和,反应效率高;2. It has two succinimide ester structural units. This group can undergo amidation reaction with the terminal amino group of the lysine residue of the protein or the N-terminal amino group of the protein. The reaction conditions are mild and the reaction efficiency is high;
3.分子骨架结构引入聚乙二醇(PEG)链,可以提高交联剂的亲水性,结合磷酸基团的亲水性,抑制交联剂透过细胞膜引起细胞内蛋白质交联,使其适用于细胞外蛋白质(如细胞表面蛋白质、分泌蛋白质、细胞外囊泡蛋白质)的特异性分析,获得上述蛋白质的结构和相互作用信息;3. The introduction of polyethylene glycol (PEG) chains into the molecular skeleton structure can improve the hydrophilicity of the cross-linking agent, combine with the hydrophilicity of the phosphate group, inhibit the cross-linking agent from penetrating the cell membrane and causing intracellular protein cross-linking, making it suitable for the specific analysis of extracellular proteins (such as cell surface proteins, secreted proteins, and extracellular vesicle proteins) to obtain the structure and interaction information of the above proteins;
4.PEG可提高交联剂的柔性,并可通过PEG链长度的调整,改变交联剂分子的交联半径,有利于捕获更多的蛋白质相互作用信息。4. PEG can improve the flexibility of the cross-linker and change the cross-linking radius of the cross-linker molecule by adjusting the length of the PEG chain, which is conducive to capturing more protein interaction information.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1PDSE化学交联剂结构式。Figure 1 Structural formula of PDSE chemical crosslinker.
图2实施例1PDSE化学交联剂的合成路线。FIG2 shows the synthetic route of the PDSE chemical crosslinker of Example 1.
图3实施例2PDSE化学交联剂与肽段的交联结果;其中,a为Ac-SAKAYEHR肽段对照及交联情况,b为Ac-IEAEKGR肽段对照及交联情况。Figure 3 shows the cross-linking results of the PDSE chemical cross-linker and the peptide in Example 2; wherein a is the control and cross-linking status of the Ac-SAKAYEHR peptide, and b is the control and cross-linking status of the Ac-IEAEKGR peptide.
图4实施例3PDSE化学交联剂与牛血清白蛋白、碳酸酐酶的交联结果。FIG. 4 shows the cross-linking results of PDSE chemical cross-linker with bovine serum albumin and carbonic anhydrase in Example 3.
图5实施例4PDSE化学交联剂与牛血清白蛋白、碳酸酐酶交联的液相色谱-质谱分析图;其中,a为PDSE交联剂与BSA交联的液相色谱-质谱分析图,b为PDSE交联剂与CA交联的液相色谱-质谱分析图。Figure 5 is a liquid chromatography-mass spectrometry analysis diagram of the cross-linking of PDSE chemical cross-linker with bovine serum albumin and carbonic anhydrase in Example 4; wherein a is a liquid chromatography-mass spectrometry analysis diagram of the cross-linking of PDSE cross-linker with BSA, and b is a liquid chromatography-mass spectrometry analysis diagram of the cross-linking of PDSE cross-linker with CA.
图6实施例4PDSE化学交联剂与牛血清白蛋白、碳酸酐酶交联的肽段数。Figure 6 shows the number of peptides cross-linked by PDSE chemical cross-linker with bovine serum albumin and carbonic anhydrase in Example 4.
具体实施方式Detailed ways
以下结合具体实施例,对本发明作进一步说明。The present invention is further described below in conjunction with specific embodiments.
实施例1Example 1
本实施例公开了一种磷酸富集型化学交联剂的制备方法,包含四个反应步骤,制备方法如下所示:This embodiment discloses a method for preparing a phosphoric acid-enriched chemical cross-linking agent, which comprises four reaction steps. The preparation method is as follows:
第一步,癸三琥珀酰亚胺酯(化合物1)的制备。将4-(2-羧基乙基)庚二酸(1.16g,5mmol)、EDCI(3.84g,20mmol)、NHS(2.3g,20mmol)溶于25ml DCM中,25℃反应24h。反应完毕,经液相分离纯化,制备柱为C18填料硅球,直径50mm,长度300mm,流动相分别为:A相为水+0.1%TFA,B相为乙腈;得到癸三琥珀酰亚胺酯溶液,经旋转蒸发干燥获得癸三琥珀酰亚胺酯(化合物1);The first step is the preparation of decantrisuccinimide ester (Compound 1). 4-(2-carboxyethyl) heptane dicarboxylic acid (1.16 g, 5 mmol), EDCI (3.84 g, 20 mmol), and NHS (2.3 g, 20 mmol) were dissolved in 25 ml DCM and reacted at 25 ° C for 24 hours. After the reaction was completed, liquid phase separation and purification were performed. The preparation column was C18 filler silica ball with a diameter of 50 mm and a length of 300 mm. The mobile phases were: phase A was water + 0.1% TFA, and phase B was acetonitrile; decantrisuccinimide ester solution was obtained, and decantrisuccinimide ester (Compound 1) was obtained by rotary evaporation and drying;
第二步,三PEG3-三羧酸(化合物2)的制备。将第一步制备的癸三琥珀酰亚胺酯(化合物1)溶于5ml DMSO中,加入氨基-PEG3-羧基(4.42g,20mmol)、TEA(5.06g,50mmol),25℃反应10min。反应完毕,反应液经过柱层析分析纯化,分离填料为200-400目硅胶,流动相为甲醇氯仿混合液,甲醇氯仿体积比控制在1:3,旋转蒸发除去有机相,得到无色油状液体三PEG3-三羧酸(化合物2)。Step 2, preparation of triPEG3-tricarboxylic acid (Compound 2). The trisuccinimidyl ester (Compound 1) prepared in the first step was dissolved in 5 ml DMSO, and amino-PEG3-carboxyl (4.42 g, 20 mmol) and TEA (5.06 g, 50 mmol) were added, and the reaction was carried out at 25°C for 10 min. After the reaction was completed, the reaction solution was purified by column chromatography, the separation filler was 200-400 mesh silica gel, the mobile phase was a methanol-chloroform mixture, and the volume ratio of methanol-chloroform was controlled at 1:3. The organic phase was removed by rotary evaporation to obtain a colorless oily liquid triPEG3-tricarboxylic acid (Compound 2).
第三步,三PEG3-三琥珀酰亚胺酯(化合物3)的制备。将第二步制备的化合物2(2.524g,3mmol)、EDCI(2.3g,12mmol)和NHS(3.15g,12mmol)加入20ml DMSO中,25℃反应24h。反应完毕,反应液缓慢滴加至相对于反应液8倍体积的THF,静置12h,除去THF,即得到无色油状物三PEG3-三琥珀酰亚胺酯(化合物3)。Step 3, preparation of triPEG3-trisuccinimide ester (Compound 3). Compound 2 (2.524 g, 3 mmol), EDCI (2.3 g, 12 mmol) and NHS (3.15 g, 12 mmol) prepared in step 2 were added to 20 ml DMSO and reacted at 25°C for 24 h. After the reaction was completed, the reaction solution was slowly added dropwise to THF 8 times the volume of the reaction solution, allowed to stand for 12 h, and THF was removed to obtain triPEG3-trisuccinimide ester (Compound 3) as a colorless oil.
第四步,PDSE(目标交联剂)的制备。将第三步制备的化合物3(1.13g,1mmol)溶于20ml DMSO中,加入TEA(304mg,3mmol),混合均匀。称取氨丙基磷酸(127.5mg,1.0mmol)溶于2mmol DMSO中,缓慢滴加至反应液,约5min滴加完毕。反应温度控制在25℃,反应时间控制在5min。反应完毕,反应液经半制备液相分离纯化,制备柱为C18填料硅球,直径50mm,长度300mm,流动相分别为A相(含0.1%体积TFA的水)和B相(含0.1%体积TFA的乙腈),采用线性梯度:从0min到40min,流动相B的含量从2%的水相增加到30%,收集32-35min流出液,真空冻干,即可得到目标交联剂PDSE。Step 4, preparation of PDSE (target crosslinker). Dissolve compound 3 (1.13 g, 1 mmol) prepared in step 3 in 20 ml DMSO, add TEA (304 mg, 3 mmol) and mix well. Weigh aminopropylphosphoric acid (127.5 mg, 1.0 mmol) and dissolve it in 2 mmol DMSO, slowly drip it into the reaction solution, and the dripping is completed in about 5 min. The reaction temperature is controlled at 25 ° C, and the reaction time is controlled at 5 min. After the reaction is completed, the reaction solution is separated and purified by semi-preparative liquid phase. The preparative column is C18 filler silica ball, with a diameter of 50 mm and a length of 300 mm. The mobile phases are phase A (water containing 0.1% volume TFA) and phase B (acetonitrile containing 0.1% volume TFA). A linear gradient is used: from 0 min to 40 min, the content of mobile phase B increases from 2% water phase to 30%, and the effluent of 32-35 min is collected and vacuum-freezed to obtain the target crosslinker PDSE.
实施例2Example 2
将PDSE交联剂应用于标准肽段Ac-SAKAYEHR(肽段1,分子量1003.07)和Ac-IEAEKGR(肽段2,分子量843.92)交联,考察PDSE交联剂与标准肽段的交联效率及质谱碎裂规律。分别取肽段1和肽段2各1mg,溶于100μl DMSO(含1%三乙胺)配制成母液。配制浓度为144.121μg/μl的PDSE交联剂母液20μl。取肽段1和肽段2母液各20μl,分别快速加入1.00μl和1.50μl PDSE交联剂溶液,涡旋振荡,25℃反应1小时。反应完毕,分别加入400μl水(0.1%甲酸),25℃水解1小时。另各取20μl肽段1和肽段2,分别加入200μl水(0.1%甲酸)作为对照。利用液相色谱(安捷伦)对样品除盐,流动相A相为98%水、2%乙腈和0.1%三氟乙酸,B相为98%乙腈、2%水和0.1%三氟乙酸,采用15分钟梯度:前3分钟为2%B相,3-8分钟为80%B相,最后7分钟为2%B相将4个样品,80%B相时出现样品峰,开始收集。将除盐后的样品利用真空冻干机进行冻干。结束后加入200μl 0.1% FA复溶。在MALDI靶板上样1μl,利用Ultra Flex III MALDI-TOF-TOF质谱仪(Bruker)进行分析,分析结果如图3所示。The PDSE crosslinker was applied to the crosslinking of standard peptides Ac-SAKAYEHR (peptide 1, molecular weight 1003.07) and Ac-IEAEKGR (peptide 2, molecular weight 843.92) to investigate the crosslinking efficiency and mass spectrometry fragmentation rules of the PDSE crosslinker with the standard peptides. Take 1 mg of peptide 1 and 1 mg of peptide 2, respectively, and dissolve them in 100 μl DMSO (containing 1% triethylamine) to prepare a mother solution. Prepare 20 μl of PDSE crosslinker mother solution with a concentration of 144.121 μg/μl. Take 20 μl of peptide 1 and peptide 2 mother solutions, quickly add 1.00 μl and 1.50 μl PDSE crosslinker solution, respectively, vortex and react at 25°C for 1 hour. After the reaction is completed, add 400 μl of water (0.1% formic acid) and hydrolyze at 25°C for 1 hour. Take 20 μl of peptide 1 and peptide 2 respectively, and add 200 μl of water (0.1% formic acid) as a control. Use liquid chromatography (Agilent) to desalt the sample, the mobile phase A is 98% water, 2% acetonitrile and 0.1% trifluoroacetic acid, the mobile phase B is 98% acetonitrile, 2% water and 0.1% trifluoroacetic acid, and the gradient is 15 minutes: the first 3 minutes is 2% B phase, 3-8 minutes is 80% B phase, and the last 7 minutes is 2% B phase. The sample peak appears at 80% B phase and begins to collect. The desalted sample is freeze-dried using a vacuum freeze dryer. After the end, add 200 μl of 0.1% FA to re-dissolve. 1 μl is loaded on the MALDI target plate and analyzed using an Ultra Flex III MALDI-TOF-TOF mass spectrometer (Bruker). The analysis results are shown in Figure 3.
实施例3Example 3
将PDSE交联剂应用于牛血清白蛋白(BSA,分子量66kDa)、碳酸酐酶(CA,分子量30kDa)交联,通过SDS-PAGE考察PDSE交联剂与蛋白的交联效率。称量1mg PDSE交联剂溶于10μl DMSO中,称量1mg DSS交联剂溶于50μl DMSO中(利用DSS高效交联剂作为对照),称量1mg BSA溶于1ml PBS,称量1mg CA溶于1ml PBS。蛋白与交联剂的摩尔浓度比设定为1:50。取100μl BSA,加入0.87μl PDSE交联剂溶液,取100μl CA,加入1.93μl PDSE交联剂溶液,取100μl BSA,加入1.38μl DSS交联剂溶液,取100μl CA,加入3.07μl DSS交联剂溶液,快速加好样品,涡旋振荡,25℃反应30分钟。加入5μl浓度为1M的碳酸氢铵溶液,25℃反应30分钟中止交联反应。另分别取不加交联剂的BSA溶液和CA溶液作为对照。上述6份样品各取10μl,加入2μl 6×SDS PAGE loading buffer,95℃水浴5分钟。配制12.5% SDS PAGE分离胶和浓缩胶,每个样品上样体积5μl,利用SDS PAGE对样品进行分析,分析结果如图4所示。PDSE crosslinker was applied to crosslink bovine serum albumin (BSA, molecular weight 66kDa) and carbonic anhydrase (CA, molecular weight 30kDa), and the crosslinking efficiency of PDSE crosslinker and protein was investigated by SDS-PAGE. Weigh 1mg PDSE crosslinker and dissolve it in 10μl DMSO, weigh 1mg DSS crosslinker and dissolve it in 50μl DMSO (using DSS high-efficiency crosslinker as control), weigh 1mg BSA and dissolve it in 1ml PBS, and weigh 1mg CA and dissolve it in 1ml PBS. The molar concentration ratio of protein to crosslinker was set to 1:50. Take 100μl BSA, add 0.87μl PDSE crosslinker solution, take 100μl CA, add 1.93μl PDSE crosslinker solution, take 100μl BSA, add 1.38μl DSS crosslinker solution, take 100μl CA, add 3.07μl DSS crosslinker solution, quickly add the sample, vortex and shake, and react at 25℃ for 30 minutes. Add 5μl of 1M ammonium bicarbonate solution and react at 25℃ for 30 minutes to terminate the crosslinking reaction. Take BSA solution and CA solution without crosslinking agent as controls. Take 10μl of each of the above 6 samples, add 2μl 6×SDS PAGE loading buffer, and water bath at 95℃ for 5 minutes. Prepare 12.5% SDS PAGE separation gel and concentration gel, load 5μl of each sample, and analyze the samples using SDS PAGE. The analysis results are shown in Figure 4.
实施例4Example 4
将PDSE交联剂应用于牛血清白蛋白(BSA,分子量66kDa)、碳酸酐酶(CA,分子量30kDa)交联,通过SDS-PAGE考察PDSE交联剂与蛋白的交联效率。称量1mg PDSE交联剂溶于10μl DMSO中,称量1mg DSS交联剂溶于50μl DMSO中(利用DSS高效交联剂作为对照),称量1mg BSA溶于1ml PBS,称量1mg CA溶于1ml PBS。蛋白与交联剂的摩尔浓度比设定为1:50。取100μl BSA,加入0.87μl PDSE交联剂溶液,取100μl CA,加入1.93μl PDSE交联剂溶液,取100μl BSA,加入1.38μl DSS交联剂溶液,取100μl CA,加入3.07μl DSS交联剂溶液,快速加好样品,涡旋振荡,25℃反应30分钟。加入5μl浓度为1M的碳酸氢铵溶液,25℃反应30分钟中止交联反应。各取70μl上述样品,加入560μl丙酮(-20℃预冷),混匀,-20℃沉淀4小时。沉淀完毕,4000g离心10分钟,弃去上清,室温挥发干沉淀。称取0.395g碳酸氢铵溶于100ml水制备碳酸氢铵溶液,称4.8g尿素加碳酸氢铵溶液至10ml,每个样品加入上述配制的100μl尿素溶液复溶。将二硫苏糖醇溶于50mM碳酸氢铵溶液配制1mol/L二硫苏糖醇溶液,每个样品加入1μl二硫苏糖醇溶液,37℃振荡2小时。将碘乙酰胺溶于50mM碳酸氢铵溶液配制1mol/L的碘乙酰胺溶液,每个样品加入2μl碘乙酰胺溶液,避光反应30分钟。反应完毕,每个样品加入700μl 50mM碳酸氢铵溶液。每个样品加入2μg Trypsin酶,37℃过夜酶解反应。反应完毕,利用液相色谱(安捷伦)对样品除盐。随后冻干样品。0.1%甲酸溶液复溶后,利用OrbitrapExploris 480高精度液质连用采集质谱数据,结果如图5和图6所示。PDSE crosslinker was applied to crosslink bovine serum albumin (BSA, molecular weight 66kDa) and carbonic anhydrase (CA, molecular weight 30kDa), and the crosslinking efficiency of PDSE crosslinker and protein was investigated by SDS-PAGE. Weigh 1mg PDSE crosslinker and dissolve it in 10μl DMSO, weigh 1mg DSS crosslinker and dissolve it in 50μl DMSO (using DSS high-efficiency crosslinker as control), weigh 1mg BSA and dissolve it in 1ml PBS, and weigh 1mg CA and dissolve it in 1ml PBS. The molar concentration ratio of protein to crosslinker was set to 1:50. Take 100μl BSA, add 0.87μl PDSE crosslinker solution, take 100μl CA, add 1.93μl PDSE crosslinker solution, take 100μl BSA, add 1.38μl DSS crosslinker solution, take 100μl CA, add 3.07μl DSS crosslinker solution, quickly add the sample, vortex and shake, and react at 25℃ for 30 minutes. Add 5μl of 1M ammonium bicarbonate solution and react at 25℃ for 30 minutes to terminate the cross-linking reaction. Take 70μl of the above samples, add 560μl acetone (pre-cooled at -20℃), mix well, and precipitate at -20℃ for 4 hours. After precipitation, centrifuge at 4000g for 10 minutes, discard the supernatant, and evaporate the dry precipitate at room temperature. Weigh 0.395g of ammonium bicarbonate and dissolve it in 100ml of water to prepare ammonium bicarbonate solution, weigh 4.8g of urea and add ammonium bicarbonate solution to 10ml, and add 100μl of the above-prepared urea solution to each sample for re-dissolution. Dissolve dithiothreitol in 50mM ammonium bicarbonate solution to prepare 1mol/L dithiothreitol solution, add 1μl of dithiothreitol solution to each sample, and shake at 37℃ for 2 hours. Dissolve iodoacetamide in 50mM ammonium bicarbonate solution to prepare 1mol/L iodoacetamide solution, add 2μl of iodoacetamide solution to each sample, and react for 30 minutes in the dark. After the reaction was completed, 700 μl of 50 mM ammonium bicarbonate solution was added to each sample. 2 μg of Trypsin enzyme was added to each sample and the enzymatic reaction was carried out at 37°C overnight. After the reaction was completed, the sample was desalted using liquid chromatography (Agilent). The sample was then freeze-dried. After re-dissolving in 0.1% formic acid solution, mass spectrometry data was collected using OrbitrapExploris 480 high-precision liquid-mass spectrometry, and the results are shown in Figures 5 and 6.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211596866.4A CN118184700A (en) | 2022-12-12 | 2022-12-12 | A phosphoric acid-enriched chemical cross-linking agent and its preparation and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211596866.4A CN118184700A (en) | 2022-12-12 | 2022-12-12 | A phosphoric acid-enriched chemical cross-linking agent and its preparation and application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN118184700A true CN118184700A (en) | 2024-06-14 |
Family
ID=91395410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211596866.4A Pending CN118184700A (en) | 2022-12-12 | 2022-12-12 | A phosphoric acid-enriched chemical cross-linking agent and its preparation and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118184700A (en) |
-
2022
- 2022-12-12 CN CN202211596866.4A patent/CN118184700A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9206225B2 (en) | Materials and methods for isolating phosphopeptides | |
CN101396650B (en) | Titanium ion fixation affinity chromatography material and preparation and use thereof | |
JP2009192548A5 (en) | ||
AU2004292202A1 (en) | Fluorous labeling for selective processing of biologically-derived samples | |
EP1437596A1 (en) | N- or C-terminal peptide selection method for proteomics | |
CN106268707A (en) | A kind of phosphoeptide based on novel magnetic porous material enrichment new method | |
Zhai et al. | Ultrasensitive analysis of heat shock protein 90α with antibodies orderly arrayed on a novel type of immunoprobe based on magnetic COFs | |
He et al. | Graft modification of cotton with phosphate group and its application to the enrichment of phosphopeptides | |
Zhai et al. | Metal ion-immobilized magnetic nanoparticles for global enrichment and identification of phosphopeptides by mass spectrometry | |
CN111777696B (en) | Method for specific reversible enrichment of nascent protein | |
CN114133425B (en) | Method for modifying protein cysteine site by propargyl sulfonium salt and application thereof | |
CN118184700A (en) | A phosphoric acid-enriched chemical cross-linking agent and its preparation and application | |
CN113683660B (en) | A method for modifying protein lysine sites and its application | |
Zheng et al. | Hydrophilic arginine-functionalized mesoporous polydopamine-graphene oxide composites for glycopeptides analysis | |
Jie et al. | A one-pot synthesis of hydrophilic poly (glycerol methacrylate) chitosan for highly selective enrichment of glycopeptides | |
CN113721028A (en) | Synthetic method and application of GO @ CS @ ZIF-8 foam material | |
CN112630446B (en) | A method for identifying binding targets of bioactive molecules based on dual-ended photoaffinity probes | |
Qu et al. | Dendrimer-Modified Silica Nanoparticles for Efficient Enrichment of Low-Concentration Peptides | |
CN117030991A (en) | Extracellular vesicle detection device and detection method | |
CN116253760A (en) | A phosphoric acid-enriched chemical cross-linking agent and its preparation method and application | |
JPS6311626B2 (en) | ||
CN114505064A (en) | Synthesis method and application of manganese-doped zinc sulfide quantum dots of glucose-6-phosphate | |
CN112521452A (en) | Polypeptide of targeted interferon gamma and application thereof | |
CN114560846B (en) | A kind of multifunctional chemical crosslinking agent and its preparation method and application | |
CN117801057A (en) | Synthesis and application of isotope probe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |